Self-collected samples to test for cervical cancer are a step in the right direction when it comes to addressing healthcare ...

The Teal Wand, an at-home HPV testing device that could replace a Pap smear, could broaden access to cervical cancer screening.

The FDA has granted approval to Teal Health's at-home cervical cancer screening wand, the first self-collection tool for HPV screening in the U.S. Kara Egan, the cofounder and CEO of Teal Health, ...

The KEYNOTE-B96 study of pembrolizumab plus paclitaxel in recurrent platinum-resistant ovarian cancer has met its primary end ...

Precision Oncology market is set for strong growth through 2035, fueled by genomic advances, rising cancer cases, and increased use of targeted therapies.

even though the drug is the only cancer immunotherapy approved for this use.

The FDA has turned down a pair of marketing applications for Regeneron’s CD20xCD3 bispecific antibody odronextamab to treat two common forms of non-Hodgkin lymphoma (NHL). The decision throws a ...

You will be redirected to our submission process. Cancer drug resistance poses a significant challenge in oncology, undermining the efficacy of chemotherapy, targeted therapy, and immunotherapy.